is compounded semaglutide less effective Navigating Semaglutide: What Health Care Providers Need to Know Semaglutide Patient Safety Updates |

Read more ADA 2026 Scientific Sessions: The GLP-1 Data That Matters The 2026 ADA Scientific Sessions delivered the GLP-1 era's biggest weight-loss number yet retatrutide at about 28% plus the first oral GLP-1 to beat semaglutide and three new contenders

When providers prescribe medicine without offering that structure, they're setting patients up to fail

In clinical trials of Wegovy, discontinuation due to gastrointestinal side effects occurred in approximately 4.5% of participants, while for Zepbound, discontinuation rates due to adverse events (primarily gastrointestinal) ranged from 4.3% to 7.1% depending on dose

Why a Tan Does Not Mean Sun Protection A darker skin tone does not make unprotected ultraviolet exposure safe

See Your Price Is It Worth the Extra Cost Over Semaglutide